Oftalmol Zh.2013;1:30-36

https://doi.org/10.31288/oftalmolzh201313036

COMPARATIVE ANALYSIS OF THE EFFICACY OF ANGIOGENESIS INHIBITORS TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION, DEPENDING ON SEVERITY OF THE DISEASE

Korol A. R.

Odessa, Ukraine

Treatment of patients with mild forms of wet AMD may as ranibizumab and pegaptonib sodium, but ranibizumab preferred therapy of severe wet AMD.

 
References
1.Король А. Р. Классификация экссудативной формы возрастной макулярной дегенерации по степени тяжести / А. Р. Король, Е. И. Драгомирецкая, Т. Б. Кустрин // Сучасні медичні технології. — 2012. — № 6. — (в печати).
2.Янковой А.  Г.  Многомерный анализ в системе STATISTICA / А. Г. Янковой // Одесса: OPTIMUM. — 2001. — 216 c.
3.Brown D. M. Ranibizumab versus verteporfm for neovascular age-related macular degeneration / D. M. Brown, P. K. Kaiser, M. Michels et al // N. Eng. J. Med. — 2006. — Vol. 355. — P. 1432- 1444.
Crossref
4.Brown D. M. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular de-generation: two-year results of the ANCHOR study / D. M. Brown, M. Michels, P. K. Kaiser et al // Ophthal-mology. — 2009. — Vol. 116. — P. 57- 65.
Crossref
5.Ding X. Molecular pathology of age-related macular degeneration / X. Ding, M. Patel, C. C. Chan // Prog. Retin. EyeRes. — 2009. — Vol. 28. — № 1. — P. 1-18.
Crossref
6.Gaudreault J. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration / J. Gaudreault, D. Fei, J. Rusit et al // Invest. Ophthalmol. Vis. Sci. — 2005. — Vol. 46. — P. 726- 733.
Crossref
7.Gonzales CR. Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis / CR Gonzales, VEGF Inhibition Study in Ocular Neovascularization (VISION) Clinical Trial Group // Retina. — 2005. — Vol. 25. — P. 815- 827.
Crossref
8.Rosenfeld P. J. Ranibizumab for neovascular age-related macular degeneration / P. J. Rosenfeld, D. M. Brown, J. S. Heier et al // N. Eng. J. Med. — 2006. — Vol. 355. — P. 1419-1431.
Crossref
9.Singh RP. Role of ranibizumab in management of macular degeneration / RP Singh, PK Kaiser // Indian J Ophthal-mol. — 2007. — Vol. 55, № 6. — P. 421- 425.
Crossref